Edition:
United States

Insider Trading: Sangamo Therapeutics Inc (SGMO.O)

SGMO.O on Nasdaq

14.15USD
10:36am EDT
Change (% chg)

$-0.15 (-1.05%)
Prev Close
$14.30
Open
$14.30
Day's High
$14.40
Day's Low
$14.10
Volume
284,576
Avg. Vol
1,522,494
52-wk High
$15.05
52-wk Low
$2.65

All Insider Trades
Trading Date Name Title Type Shares Traded Price
31 Aug 2017

Herberts (Curt A III)

Officer Sell 4,684 $15.00
31 Aug 2017

Herberts (Curt A III)

Officer Buy 10,316 $5.41
31 Aug 2017

Herberts (Curt A III)

Officer Sell 10,316 $15.00
13 Aug 2017

Herberts (Curt A III)

Officer Buy 5,000 $5.12
13 Aug 2017

Herberts (Curt A III)

Officer Sell 5,000 $11.00
10 Aug 2017

Herberts (Curt A III)

Officer Buy 3,000 $2.55
10 Aug 2017

Herberts (Curt A III)

Officer Sell 6,474 $10.00
10 Aug 2017

Herberts (Curt A III)

Officer Buy 3,474 $3.99
13 Jul 2017

Herberts (Curt A III)

Officer Buy 172 $3.99
13 Jul 2017

Herberts (Curt A III)

Officer Sell 172 $10.00
13 Jul 2017

Herberts (Curt A III)

Officer Sell 14,828 $10.00
31 May 2017

Herberts (Curt A III)

Officer Sell 2,000 $6.80
11 May 2017

Herberts (Curt A III)

Officer Sell 2,000 $8.50
10 May 2017

Herberts (Curt A III)

Officer Sell 639 $6.50
11 Dec 2016

Lanphier (Edward O II)

Director Gift 30,000 $0.00
11 Dec 2016

Herberts (Curt A III)

Chairman of the Board Sell 4,852 $3.05
12 Jun 2016

Lanphier (Edward O II)

Director Sell 16,107 $6.23
12 Jun 2016

Lanphier (Edward O II)

Director Sell 21,741 $6.23
12 Jun 2016

Lanphier (Edward O II)

Director Sell 15,658 $6.23
12 Jun 2016

Lanphier (Edward O II)

Director Sell 9,395 $6.23
12 Jun 2016

Lanphier (Edward O II)

Director Sell 21,741 $6.23
6 Jun 2016

Lanphier (Edward O II)

Director Gift 50,000 $0.00
10 Mar 2016

Lanphier (Edward O II)

Director Gift 8,000 $0.00
11 Dec 2015

Wolff (Henry Ward)

Chief Financial Officer Sell 6,087 $8.68
11 Dec 2015

Wolff (Henry Ward)

Chief Financial Officer Sell 13,778 $3.05

Institutional Holders

% Shares Owned: 63.84%
# of Holders: 193
Total Shares Held: 53,377,407
3 Mo. Net Change: 11,137,337
# New Positions: 41
# Closed Positions: 16
# Increased Positions: 91
# Reduced Positions: 62
# Net Buyers: 29

Officers & Directors

Name Age Since Current Position

Alexander Macrae

2016 President, Chief Executive Officer, Director

Kathy Yi

45 2017 Chief Financial Officer, Senior Vice President

Dale Ando

60 2004 Vice President - Therapeutic Development, Chief Medical Officer

Roger Jeffs

2017 Director

H. Stewart Parker

59 2014 Director

William Ringo

71 2016 Director

Joseph Zakrzewski

54 2017 Director

Stephen Dilly

57 2010 Independent Director

John Larson

81 1996 Independent Director

Steven Mento

63 2005 Independent Director

Saira Ramasastry

39 2012 Independent Director

Elizabeth Wolffe

IR Contact Officer, Corporate Communications